Imperial College London

Professor David Nutt DM, FRCP, FRCPsych, FSB, FMedSci

Faculty of MedicineDepartment of Brain Sciences

The Edmond J Safra Chair in Neuropsychopharmacology
 
 
 
//

Contact

 

d.nutt

 
 
//

Location

 

Burlington Danes BuildingBurlington DanesHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Sforzini:2022:10.1038/s41380-021-01381-x,
author = {Sforzini, L and Worrell, C and Kose, M and Anderson, IM and Aouizerate, B and Arolt, V and Bauer, M and Baune, BT and Blier, P and Cleare, AJ and Cowen, PJ and Dinan, TG and Fagiolini, A and Ferrier, IN and Hegerl, U and Krystal, AD and Leboyer, M and McAllister-Williams, RH and McIntyre, RS and Meyer-Lindenberg, A and Miller, AH and Nemeroff, CB and Normann, C and Nutt, D and Pallanti, S and Pani, L and Penninx, BWJH and Schatzberg, AF and Shelton, RC and Yatham, LN and Young, AH and Zahn, R and Aislaitner, G and Butlen-Ducuing, F and Fletcher, C and Haberkamp, M and Laughren, T and Mantyla, F-L and Schruers, K and Thomson, A and Arteaga-Henriquez, G and Benedetti, F and Cash-Gibson, L and Chae, WR and De, Smedt H and Gold, SM and Hoogendijk, WJG and Mondragon, VJ and Maron, E and Martynowicz, J and Melloni, E and Otte, C and Perez-Fuentes, G and Poletti, S and Schmidt, ME and van, de Ketterij E and Woo, K and Flossbach, Y and Ramos-Quiroga, JA and Savitz, AJ and Pariante, CM},
doi = {10.1038/s41380-021-01381-x},
journal = {MOLECULAR PSYCHIATRY},
pages = {1286--1299},
title = {A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials},
url = {http://dx.doi.org/10.1038/s41380-021-01381-x},
volume = {27},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Sforzini,L
AU - Worrell,C
AU - Kose,M
AU - Anderson,IM
AU - Aouizerate,B
AU - Arolt,V
AU - Bauer,M
AU - Baune,BT
AU - Blier,P
AU - Cleare,AJ
AU - Cowen,PJ
AU - Dinan,TG
AU - Fagiolini,A
AU - Ferrier,IN
AU - Hegerl,U
AU - Krystal,AD
AU - Leboyer,M
AU - McAllister-Williams,RH
AU - McIntyre,RS
AU - Meyer-Lindenberg,A
AU - Miller,AH
AU - Nemeroff,CB
AU - Normann,C
AU - Nutt,D
AU - Pallanti,S
AU - Pani,L
AU - Penninx,BWJH
AU - Schatzberg,AF
AU - Shelton,RC
AU - Yatham,LN
AU - Young,AH
AU - Zahn,R
AU - Aislaitner,G
AU - Butlen-Ducuing,F
AU - Fletcher,C
AU - Haberkamp,M
AU - Laughren,T
AU - Mantyla,F-L
AU - Schruers,K
AU - Thomson,A
AU - Arteaga-Henriquez,G
AU - Benedetti,F
AU - Cash-Gibson,L
AU - Chae,WR
AU - De,Smedt H
AU - Gold,SM
AU - Hoogendijk,WJG
AU - Mondragon,VJ
AU - Maron,E
AU - Martynowicz,J
AU - Melloni,E
AU - Otte,C
AU - Perez-Fuentes,G
AU - Poletti,S
AU - Schmidt,ME
AU - van,de Ketterij E
AU - Woo,K
AU - Flossbach,Y
AU - Ramos-Quiroga,JA
AU - Savitz,AJ
AU - Pariante,CM
DO - 10.1038/s41380-021-01381-x
EP - 1299
PY - 2022///
SN - 1359-4184
SP - 1286
TI - A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
T2 - MOLECULAR PSYCHIATRY
UR - http://dx.doi.org/10.1038/s41380-021-01381-x
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000730089500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 27
ER -